Viewing Study NCT03987620


Ignite Creation Date: 2025-12-25 @ 4:07 AM
Ignite Modification Date: 2026-02-24 @ 12:02 PM
Study NCT ID: NCT03987620
Status: COMPLETED
Last Update Posted: 2021-09-08
First Post: 2019-06-12
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis
Sponsor: Scynexis, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Candida Vulvovaginitis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Vaginitis View
None Yeast infection View